UroGen Pharma Ltd. (URGN) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$14,512
Total Return
45.12%
CAGR
7.73%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +4.50% |
| Median | -1.66% |
| Best | +245.09% |
| Worst | -64.03% |
| % of Windows Positive | 45.6% |
1-Year (252 Trading Days)
| Average | +32.16% |
| Median | +20.51% |
| Best | +630.03% |
| Worst | -70.47% |
| % of Windows Positive | 60.0% |
3-Year (756 Trading Days)
| Average | +65.92% |
| Median | +59.19% |
| Best | +279.12% |
| Worst | -42.29% |
| % of Windows Positive | 79.2% |
Risk Metrics
| Maximum Drawdown | -82.64% |
| Average Drawdown | -38.49% |
| Drawdown Duration | 561 Trading Days |
| Sortino Ratio | 0.89 |
| Calmar Ratio | 0.09 |
| CVaR (5%) | -9.72% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +13.58% (+35.25% ann.) | +$1357.82 | $0.00 | $0.00 | $0.00 |
| 2025 | +119.91% | +$11990.59 | $0.00 | $0.00 | $0.00 |
| 2024 | -29.00% | $2899.99 | $0.00 | $0.00 | $0.00 |
| 2023 | +69.11% | +$6910.93 | $0.00 | $0.00 | $0.00 |
| 2022 | -6.73% | $672.98 | $0.00 | $0.00 | $0.00 |
| 2021 | -47.23% | $4722.53 | $0.00 | $0.00 | $0.00 |
| 2020 | -46.00% | $4599.94 | $0.00 | $0.00 | $0.00 |
| 2019 | -22.50% | $2250.35 | $0.00 | $0.00 | $0.00 |
| 2018 | +15.72% | +$1572.16 | $0.00 | $0.00 | $0.00 |
| 2017 partial | +166.17% (+346.41% ann.) | +$16616.60 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 4, 2017 – February 19, 2020 | +114.02% | +31.29% | +$11402.00 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -46.38% | -99.92% | $4638.02 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +31.21% | +54.82% | +$3121.19 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -52.11% | -50.27% | $5210.93 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -9.26% | -9.81% | $926.39 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +39.87% | +19.84% | +$3986.94 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +103.05% | +51.48% | +$10305.34 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.